Authors: | Altman, J. K.; Tallman, M. S. |
Article Title: | "Boldness be my friend" (Shakespeare; Cymbeline) |
Abstract: | Au et al. report in this issue of Blood that oral arsenic trioxide (ATO) may be safely used in maintenance therapy in acute promyelocytic leukemia (APL).1 This is a major improvement in convenience given that intravenous (IV) ATO requires daily administration for weeks at a time. In addition, the oral formulation may be less toxic. The time seems right to carefully explore the introduction of oral ATO earlier in treatment of the disease. |
Journal Title: | Blood |
Volume: | 118 |
Issue: | 25 |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2011-12-15 |
Start Page: | 6477 |
End Page: | 6478 |
Language: | English |
DOI: | 10.1182/blood-2011-11-386557 |
PROVIDER: | scopus |
PUBMED: | 22174303 |
DOI/URL: | |
Notes: | --- - "Export Date: 1 February 2012" - "CODEN: BLOOA" - "Source: Scopus" |